Waverley Pharma Inc. (FRA:5GZ)
0.0120
0.00 (0.00%)
Last updated: Jan 28, 2026, 3:25 PM CET
Waverley Pharma Revenue
Waverley Pharma had revenue of 275.66K CAD in the quarter ending September 30, 2025, with 1,129.68% growth. This brings the company's revenue in the last twelve months to 1.51M, up 2,016.26% year-over-year. In the year 2024, Waverley Pharma had annual revenue of 475.37K with 15.36% growth.
Revenue (ttm)
1.51M CAD
Revenue Growth
+2,016.26%
P/S Ratio
1.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.00M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 475.37K | 63.28K | 15.36% |
| Dec 31, 2023 | 412.09K | -834.74K | -66.95% |
| Dec 31, 2022 | 1.25M | -506.02K | -28.87% |
| Dec 31, 2021 | 1.75M | 377.74K | 27.47% |
| Dec 31, 2020 | 1.38M | 217.83K | 18.82% |
| Dec 31, 2019 | 1.16M | 933.87K | 418.03% |
| Dec 31, 2018 | 223.40K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Manz AG | 205.12M |
| Paion AG | 14.81M |
| a.i.s. AG | 12.43M |
| Medigene AG | 7.45M |
| Instant Group AG | 1.54M |
| Valora Effekten Handel AG | 782.05K |
| elexxion AG | 301.69K |
| Arzneiwerk AG VIDA | 124.96K |